3
Announcements
Trials
Browse
Landscape
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Stomach Neoplasms
3
Breast Neoplasms
3
Endometrial Neoplasms
2
Thyroid Neoplasms
1
Thyroid Diseases
1
Thoracic Neoplasms
1
Rectal Neoplasms
1
Peritoneal Neoplasms
1
Parathyroid Diseases
1
Ovarian Neoplasms
1
Neovascularization, Pathologic
1
Neoplasms by Site
1
Neoplasms
1
Lymphedema
1
Lung Neoplasms
1
Lung Diseases
1
Hypoparathyroidism
1
Gastrointestinal Stromal Tumors
1
Gastrointestinal Diseases
1
Carcinoma, Hepatocellular
1
Adenoma
1
Interventions
Sorafenib
3
vandetanib
2
alectinib
2
Sodium
2
Magnetic Resonance Spectroscopy
2
Imatinib Mesylate
2
Bevacizumab
2
tremelimumab
1
temsirolimus
1
ponatinib
1
perflutren
1
pembrolizumab
1
methyl N-acetylsibirosaminide
1
lenvatinib
1
gallium 68 PSMA-11
1
fosbretabulin
1
durvalumab
1
combretastatin
1
cobimetinib
1
cabozantinib
1
X-Rays
1
Valproic Acid
1
Thyroxine
1
Technetium Tc 99m Sestamibi
1
Sirolimus
1
Radiofrequency Ablation
1
Presenilin-1
1
Paclitaxel
1
PLX8394
1
Lubricant Eye Drops
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Thyroid Neoplasms
×
Indocyanine Green
×
Clear all
NCT05328076
2024-07-05
ANGIO_PARA
IRCCS San Raffaele
Terminated
22 enrolled